| Univariable analysis | Multivariable analysis | ||||
---|---|---|---|---|---|---|
Odds ratio (95% CI) | p value | Model 1 | Model 2 | |||
Odds ratio (95% CI) | p value | Odds ratio (95% CI) | p value | |||
Sex | 0.99 (0.55, 1.89) | 0.98 | 0.88 (0.45, 1.71) | 0.71 | 0.83 (0.43, 1.63) | 0.59 |
Age (10Â years) | 1.01 (0.84, 1.29) | 0.98 | 0.83 (0.68, 1.01) | 0.07 | 0.83 (0.68, 1.01) | 0.06 |
DAS28-CRP non-remission | 1.99 (1.12, 3.36) | 0.01 | 0.93 (0.48, 1.78) | 0.82 | Â | Â |
TJC | 1.18 (1.03, 1.35) | 0.02 | Â | Â | 1.02 (0.85, 1.22) | 0.85 |
SJC | 1.14 (0.98, 1.34) | 0.08 | Â | Â | 0.97 (0.79, 1.19) | 0.76 |
CRP | 1.23 (0.90, 1.65) | 0.17 | Â | Â | 1.01 (0.70, 1.43) | 0.98 |
PtGA (0–10) | 1.29 (1.18, 1.42) |  < 0.01 |  |  | 1.15 (1.02, 1.29) | 0.03 |
HAQ-DI non-remission | 4.32 (2.59, 7.48) |  < 0.01 | 3.51 (1.85, 6.64) |  < 0.01 | 3.21 (1.69, 6.08) |  < 0.01 |
Pain VAS (0–10) | 1.24 (1.14, 1.35) |  < 0.01 | 1.10 (0.98, 1.23) | 0.12 |  |  |
Biological DMARD | 1.12 (0.69, 1.77) | 0.65 | 1.07 (0.63, 1.80) | 0.81 | 1.05 (0.62, 1.77) | 0.85 |
Methotrexate | 0.64 (0.40, 1.03) | 0.06 | 0.67 (0.40, 1.13) | 0.13 | 0.71 (0.42, 1.20) | 0.20 |
Steroid | 1.63 (1.01, 2.60) | 0.04 | 1.12 (0.66, 1.92) | 0.67 | 1.14 (0.66, 1.96) | 0.64 |